loading
Precedente Chiudi:
$4.86
Aprire:
$4.79
Volume 24 ore:
44,841
Relative Volume:
0.18
Capitalizzazione di mercato:
$55.61M
Reddito:
$52.29M
Utile/perdita netta:
$-73.52M
Rapporto P/E:
-7.5985
EPS:
-0.66
Flusso di cassa netto:
$-100.45M
1 W Prestazione:
+10.95%
1M Prestazione:
+10.71%
6M Prestazione:
+0.30%
1 anno Prestazione:
-49.60%
Intervallo 1D:
Value
$4.51
$5.03
Intervallo di 1 settimana:
Value
$4.40
$5.03
Portata 52W:
Value
$3.61
$11.09

Precision Biosciences Inc Stock (DTIL) Company Profile

Name
Nome
Precision Biosciences Inc
Name
Telefono
919-314-5512
Name
Indirizzo
302 EAST PETTIGREW STREET, DURHAM, NC
Name
Dipendente
107
Name
Cinguettio
@PrecisionBioSci
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
DTIL's Discussions on Twitter

Confronta DTIL con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
DTIL
Precision Biosciences Inc
5.015 49.34M 52.29M -73.52M -100.45M -0.66
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.54 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.81 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.40 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
569.92 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.36 29.19B 3.81B -644.79M -669.77M -6.24

Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-01-10 Aggiornamento BMO Capital Markets Market Perform → Outperform
2024-04-30 Iniziato Guggenheim Buy
2022-06-17 Iniziato BMO Capital Markets Outperform
2022-06-09 Downgrade William Blair Outperform → Mkt Perform
2020-07-27 Ripresa BTIG Research Buy
2020-04-03 Downgrade Goldman Buy → Neutral
2020-03-05 Iniziato Stifel Buy
2020-02-25 Iniziato William Blair Outperform
2019-08-09 Iniziato BTIG Research Buy
2019-07-16 Iniziato H.C. Wainwright Buy
2019-04-22 Iniziato Barclays Overweight
2019-04-22 Iniziato Goldman Buy
2019-04-22 Iniziato JP Morgan Overweight
2019-04-22 Iniziato Jefferies Buy
Mostra tutto

Precision Biosciences Inc Borsa (DTIL) Ultime notizie

pulisher
09:04 AM

Precision BioSciences Receives FDA Orphan Drug Designation for PBGENE-DMD - Contract Pharma

09:04 AM
pulisher
08:36 AM

What analysts say about Precision BioSciences Inc. stockFree Trading Strategy Suggestions - Autocar Professional

08:36 AM
pulisher
08:12 AM

Precision BioSciences stock rises after FDA grants orphan drug status By Investing.com - Investing.com Canada

08:12 AM
pulisher
07:14 AM

FDA grants orphan drug status to Precision BioSciences’ DMD treatment - Investing.com Australia

07:14 AM
pulisher
07:01 AM

Precision BioSciences Receives FDA Orphan Drug Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy - Business Wire

07:01 AM
pulisher
Jul 22, 2025

What drives Precision BioSciences Inc. stock priceFastest return on investment - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Precision BioSciences Inc. Stock Analysis and ForecastFree Capital Growth Strategies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

Precision BioSciences Secures Orphan Drug Designation for DMD Treatment, DTIL Stock News - AInvest

Jul 19, 2025
pulisher
Jul 17, 2025

Precision BioSciences Duchenne muscular dystrophy treatment gets orphan status - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Precision BioSciences gets FDA orphan drug designations for DMD treatment By Investing.com - Investing.com Canada

Jul 17, 2025
pulisher
Jul 16, 2025

Precision BioSciences reports promising DMD gene editing results By Investing.com - Investing.com Canada

Jul 16, 2025
pulisher
Jul 16, 2025

Precision BioSciences Highlights New Preclinical Data for PBGENE-DMD Further Supporting Advancement of Novel Gene Editing Approach for the Treatment of Duchenne Muscular Dystrophy Towards Clinic - Business Wire

Jul 16, 2025
pulisher
Jul 16, 2025

How Precision BioSciences Inc. stock performs during market volatilityFree Market Sentiment Analysis - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Precision Bio's DMD Therapy Gets Rare Pediatric Status, But Stock Slides; Retail Crowd Sees ‘Good Risk-Reward’ - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

Why Precision BioSciences Inc. stock attracts strong analyst attentionPortfolio Boosting Stock Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Precision BioSciences Inc. stock price move sharplyTriple Digit Return Forecasts - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

(DTIL) Proactive Strategies - news.stocktradersdaily.com

Jul 12, 2025
pulisher
Jul 08, 2025

Precision Biosciences CFO Sells Shares to Cover Tax Obligations - TradingView

Jul 08, 2025
pulisher
Jun 30, 2025

Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 3000E Value Index - MarketScreener

Jun 30, 2025
pulisher
Jun 27, 2025

Insider Buying: Kevin Buehler Acquires Shares of Precision BioSciences Inc (DTIL) - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

Precision Biosciences director Brown buys $6963 in DTIL stock - Investing.com

Jun 27, 2025
pulisher
Jun 25, 2025

Precision BioSciences stock jumps after FDA grants rare pediatric designation By Investing.com - Investing.com UK

Jun 25, 2025
pulisher
Jun 18, 2025

A startup banks $66M to pursue ‘inclusive precision medicine’ - BioPharma Dive

Jun 18, 2025
pulisher
Jun 03, 2025

precision biosciences reports voting outcomes at annual shareholder meeting By Investing.com - Investing.com Australia

Jun 03, 2025
pulisher
Jun 03, 2025

precision biosciences reports voting outcomes at annual shareholder meeting - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Precision BioSciences Holds Annual Stockholder Meeting - TipRanks

Jun 03, 2025
pulisher
May 21, 2025

Precision BioSciences (DTIL): Rating Reaffirmed at Buy with $60 Target | DTIL Stock News - GuruFocus

May 21, 2025
pulisher
May 16, 2025

Precision BioSciences: Q1 Earnings Snapshot - CT Insider

May 16, 2025
pulisher
May 16, 2025

Precision BioSciences Reports Q1 2025 Financial Results - TipRanks

May 16, 2025
pulisher
May 15, 2025

Transcript : Precision BioSciences, Inc.Special Call - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Precision BioSciences Inc Reports Q1 2025 EPS of $(2.21) and Rev - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Precision BioSciences Reports Q1 Results and Business Update - TipRanks

May 15, 2025
pulisher
May 15, 2025

Precision BioSciences (DTIL) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Precision BioSciences (DTIL) Reports Robust Q1 Revenue and Advan - GuruFocus

May 15, 2025

Precision Biosciences Inc Azioni (DTIL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.80
price up icon 4.56%
$35.91
price down icon 0.55%
$102.84
price down icon 0.11%
$27.78
price up icon 4.63%
$113.51
price up icon 1.86%
biotechnology ONC
$295.56
price up icon 0.00%
Capitalizzazione:     |  Volume (24 ore):